Apoquel (oclacitinib) Tablets for Dogs

Type: Prescription anti‑itch and anti‑inflammatory tablet for dogs with allergic dermatitis and atopic dermatitis.

Indications

• Control of pruritus associated with allergic dermatitis in dogs.
• Treatment of the clinical manifestations of atopic dermatitis in dogs.

Dosage and Administration

• Initial phase: 0.4–0.6 mg/kg orally twice daily for up to 14 days.
• Maintenance: 0.4–0.6 mg/kg orally once daily.
• Tablets may be given with or without food; available strengths: 3.6 mg, 5.4 mg, 16 mg (scored, divisible).

Onset and Benefits

• Rapid relief of itch with improvement typically within hours and sustained control with maintenance dosing.
• Targeted cytokine pathway inhibition to reduce itch and inflammation while enabling multimodal allergy management.

Use Restrictions

• For dogs at least 12 months of age and ≥3 kg body weight.
• Do not use in dogs with evidence of immunosuppression or progressive malignant neoplasia.

Precautions

• Oclacitinib modulates the immune system and may increase susceptibility to infections and potentially exacerbate neoplastic conditions; monitor during therapy.
• Investigate and manage underlying causes of allergic dermatitis (e.g., fleas, food, contact) and treat complicating infections.

Pack Information

Film‑coated tablets: 3.6 mg (S), 5.4 mg (M), 16 mg (L); scored to allow halving for accurate dosing.